Metro North Train Derailment - December 1, 2013
Our hearts go out to the families and loved ones of those who died and were injured in the Train Derailment in New York on December 1, 2013. The Metropolitan Transportation Authority ("MTA") has one of the busiest public transit systems in the world. Because of the number of passengers who rely on trains as their preferred mode of transportation on a daily basis, the MTA has a duty to ensure that its trains are safe. This is the third train accident involving MTA trains just this year. Preliminary reports suggest that this recent accident could have been prevented as it was due to excessive speed. Due to the frequency of these accidents, passengers and their loved ones need to be aware of their rights and how they should proceed if they or a loved one are injured. Anyone who many have been injured in this accident should consult an experienced attorney for a professional evaluation of their situation and an appraisal of their rights. For more information, please contact one of our skilled attorneys for a free case consultation.
If you or someone you know has been injured in a train accident, contact the lawyers at Lynch,Traub, Keefe & Errante for a free consultation. Our experience and proven track record will get you results.
We are currently investigating and evaluating potential cases involving diabetes patients who were treated with Byetta, Januvia and/or Victoza and diagnosed with pancreatic or thyroid cancer. Recent studies have demonstrated an association between these diabetes medications and the development of pancreatic or thyroid cancer. Byetta, Januvia and Victoza are new generation diabetes medications that are currently prescribed in the United States. Byetta and Victoza are injectible medications while Januvia is taken orally. All three medications are referred to as "GLP-1 Agents" – so named for the human hormone which is the target of their action.
If you or someone you know has been injured by Byetta, Januvia and/or Victoza, please contact our law firm for a free consultation.
We are currently investigating and evaluating bleeding injuries associated with the use of Pradaxa®, an anti-clotting medication approved to prevent the formation of blood clots in patients with atrial fibrillation, an abnormal heartbeat. Pradaxa is a medication which, by thinning the blood, can reduce the risk of the formation of blood clots which can result in a stroke. Pradaxa, however, has no effective reversal agent and the danger for those taking Pradaxa is a potentially lethal and irreversible bleeding event.
If you or someone you know has been injured by Pradaxa, please contact our law firm for a free consultation.